| P/E (FY) | — | Sales (TTM) | $569.6M |
| Earnings (TTM) | $10.6M | ROE | −2.40% |
| Net Margin | −2.14% | ROIC | −1.90% |
| Debt / Equity | 0.13 | TD / EBITDA | — |
| EPS Growth 3Y | — | Sales Growth 3Y | 17.40% |
AtriCure, Inc. develops, manufactures, and sells devices for surgical ablation of cardiac tissue, exclusion of the left atrial appendage, and temporary pain relief by ablating peripheral nerves, serving medical centers in the United States, Asia-Pacific, and internationally. Its products include the Isolator Synergy Ablation System, multifunctional pens and linear ablation devices, the cryoICE Cryoablation System, EPi-Sense Systems for atrial fibrillation, and the cryoSPHERE probe for temporary pain relief.
| Market Cap | $2.02B | Trading Days | 5273 |
| 52W High | 43.18 |
| 52W Low | 25.37 |
| % Off High | −7.94% |
| YTD | 0.48% | 1Y | 19.66% |
| 3Y | −28.18% | 5Y | −51.65% |
| 10Y | 170.04% | Since incept. (ann.) | 5.07% |
US 69% · Non Us 16% · Europe 10% · Asia Pacific 5% · …
| Ann. Volatility (1Y) | 47.98% | Ann. Volatility (3Y) | 48.33% |
| Sharpe (1Y) | 0.62 | Sharpe (3Y) | 0.02 |
| Max Drawdown (1Y) | −39.02% | Max Drawdown (3Y) | −65.30% |
| Beta (3Y, vs SPY) | 1.04 |
| Ticker | Name | Mkt cap | P/E |
|---|---|---|---|
| UFPT | UFP TECHNOLOGIES INC | $2.00B | 29.5 |
| NVCR | NovoCure Ltd | $1.90B | — |
| HTFL | Heartflow, Inc. | $2.21B | — |
| LMAT | LEMAITRE VASCULAR INC | $2.34B | 40.6 |
| PLSE | PULSE BIOSCIENCES, INC. | $2.45B | — |
| IART | INTEGRA LIFESCIENCES HOLDINGS CORP | $1.54B | — |
| INSP | Inspire Medical Systems, Inc. | $1.50B | 10.6 |
| ATEC | Alphatec Holdings, Inc. | $1.41B | — |
| KMTS | KESTRA MEDICAL TECHNOLOGIES, LTD. | $1.40B | — |
| AORT | ARTIVION, INC. | $1.31B | 128.6 |
| TNDM | TANDEM DIABETES CARE INC | $1.22B | — |
| IRMD |
| IRADIMED CORP |
| $1.21B |
| 54.2 |
